Skip to main content
Clinical Trials/NCT05339945
NCT05339945
Completed
Not Applicable

Towards an Early Integration of Palliative Care in Oncology: Descriptive Study of Needs for Patients With Metastatic Cancer and the Adequacy of These Needs With Healthcare Facilities

Assistance Publique - Hôpitaux de Paris1 site in 1 country361 target enrollmentJune 2, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Metastatic Cancer
Sponsor
Assistance Publique - Hôpitaux de Paris
Enrollment
361
Locations
1
Primary Endpoint
Auto-evaluation
Status
Completed
Last Updated
last year

Overview

Brief Summary

The primary objective of the study is to describe the nature and to estimate the prevalence the health needs of patients with metastatic cancer and their main caregivers, between the period from diagnosis to death.

As secondary objectives, the study aims:

  • to determinate the proportion of patients with an indication for palliative care according to Hui et al., and to describe the adequation of health needs and the services for them;
  • to study the association between clinical pathway and the indication of targeted palliative care;
  • to study the association between the integration of palliative care service and the adequation of health needs service of patients;
  • to study the factors such as the disease, the practice and the care, contribute to the patient's survivor of 1 year.

Detailed Description

This is a descriptive, transversal, multicenter study, which will be performed in healthcare facilities in Ile de France area. Each investigator center will be composed by oncologist / palliative care and support team. 10 centers will participate to the study, enrollement will be perfomed during 6 months targetting 400 patients with advanced cancer.

Registry
clinicaltrials.gov
Start Date
June 2, 2022
End Date
October 21, 2024
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients ≥ 18 years;
  • Diagnosed metastatic cancer;
  • Outpatient or inpatient care at a participating site to the study;
  • Affiliation to the social security scheme;
  • Patient informed and non-opposed to participate to the study.

Exclusion Criteria

  • Testicular or choriocarcinoma ovarian cancer;
  • Hematology cancer;
  • No understanding french language;
  • Unable to express if needed his non-opposition opinion, according to physician investigator;
  • Visually impaired, hearing impaired or aphasic.

Outcomes

Primary Outcomes

Auto-evaluation

Time Frame: at baseline

Evaluation by patient and principal caregiver the health needs. Questionnaires: Echelle de Zarit.

Secondary Outcomes

  • Clinical trajectory description(at baseline)
  • Survivor (%)(at 1 year)
  • Description of disease(at baseline)
  • Proportion (%) of patients needing palliative treatment(at the end of study)

Study Sites (1)

Loading locations...

Similar Trials